PHARMACEUTICAL PRODUCT DEVELOPMENT INC Defined Benefit Plan, Net Periodic Benefit Cost (Credit)
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Defined Benefit Plan, Net Periodic Benefit Cost (Credit) of $283.00 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC defined benefit plan, net periodic benefit cost (credit) for the quarter ending 2011-09-30 was $283.00K, a 35.68% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC defined benefit plan, net periodic benefit cost (credit) for the quarter ending 2011-06-30 was $287.00K, a 32.31% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC defined benefit plan, net periodic benefit cost (credit) for the quarter ending 2010-09-30 was $440.00K.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC defined benefit plan, net periodic benefit cost (credit) for the quarter ending 2010-06-30 was $424.00K.
| Period end | Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 3 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 6 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 9 month |
|---|---|---|---|
| 2011-09-30 | $283.00K 10-Q · filed 2011-11-02 | $570.00K derived: sum of 2 quarters · filed 2011-11-02 | $853.00K 10-Q · filed 2011-11-02 |
| 2011-06-30 | $287.00K 10-Q · filed 2011-08-04 | $570.00K 10-Q · filed 2011-08-04 | |
| 2010-09-30 | $440.00K 10-Q · filed 2011-11-02 | $864.00K derived: sum of 2 quarters · filed 2011-11-02 | $1.31M 10-Q · filed 2011-11-02 |
| 2010-06-30 | $424.00K 10-Q · filed 2011-08-04 | $867.00K 10-Q · filed 2011-08-04 |